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Background: Rupture of advanced atherosclerotic plaques accounts for most life-
threatening myocardial infarctions. Classical (M1) and alternative (M2) macrophage activa-
tion could promote atherosclerotic plaque progression and rupture by increasing production
of proteases, including matrix metalloproteinases (MMPs). Lymphocyte-derived cytokines
may be essential for generating M1 and M2 phenotypes in plaques, although this has not
been rigorously tested until now.
Methods and results: We validated the expression of M1 markers (iNOS and COX-2)
and M2 markers (arginase-1, Ym-1, and CD206) and then measured MMP mRNA lev-
els in mouse macrophages during classical and alternative activation in vitro. We then
compared mRNA expression of these genes ex vivo in foam cells from subcutaneous
granulomas in fat-fed immune-competent ApoE knockout (KO) and immune-compromised
ApoE/Rag-1 double-KO mice, which lack all T and B cells. Furthermore, we performed
immunohistochemistry in subcutaneous granulomas and in aortic root and brachiocephalic
artery atherosclerotic plaques to measure the extent of M1/M2 marker and MMP protein
expression in vivo. Classical activation of mouse macrophages with bacterial lipopolysac-
charide in vitro increased MMPs-13, -14, and -25 but decreased MMP-19 andTIMP-2 mRNA
expressions. Alternative activation with IL-4 increased MMP-19 expression. Foam cells in
subcutaneous granulomas expressed all M1/M2 markers and MMPs at ex vivo mRNA and
in vivo protein levels, irrespective of Rag-1 genotype.There were also similar percentages
of foam cell macrophages (FCMs) carrying M1/M2 markers and MMPs in atherosclerotic
plaques from ApoE KO and ApoE/Rag-1 double-KO mice.
Conclusion: Classical and alternative activation leads to distinct MMP expression patterns
in mouse macrophages in vitro. M1 and M2 polarization in vivo occurs in the absence of T
and B lymphocytes in either granuloma or plaque FCMs.
Keywords: atherosclerosis, macrophages, lymphocytes, cytokines, plaque rupture
INTRODUCTION
Atherosclerotic plaque rupture underlies most myocardial infarc-
tions and thromboembolic strokes, which are principal causes
of mortality and morbidity worldwide (https://apps.who.int/
infobase/mortality.aspx). Macrophages play a key role in ather-
osclerosis progression, as demonstrated by their abundance in
human plaques as foam cells and by the dramatic reduction in
atherosclerosis in mice after genetic (1) or pharmacological (2)
deletion of macrophages. Furthermore, production of mediators
from activated macrophages is believed to be important in mak-
ing plaques vulnerable to rupture (3). Reactive oxygen species,
cytokines, and cell surface modifying proteinases produced by
macrophages promote apoptosis, thereby contributing to the cel-
lular rarefaction of vulnerable plaques (4). Moreover, extracellular
proteinases, in particular matrix metalloproteinases (MMPs) can
directly degrade the extracellular matrix and promote plaque
instability (5). These proposed mechanisms are supported by the
histological appearance of vulnerable plaques, which contain an
abundance of macrophages expressing MMPs but a relative lack
of smooth muscle cells (SMC) and extracellular matrix proteins,
importantly collagens, which contribute tensile strength to the
plaque cap (5). Intervening to diminish the production of these
harmful mediators is therefore a rational approach to new ther-
apies and this motivates efforts to understand the cellular and
molecular mechanisms involved.
Early work highlighted the functional diversity of macrophages
(6) and the existence of distinct phenotypes has become increas-
ingly discussed (7). Polarization of macrophage into a so-called
classically activated or M1 phenotype was recognized, possibly
reflecting the context of infection where pathogen associated
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molecular patterns (PAMPs) and pro-inflammatory lymphocyte-
derived cytokines, particularly interferons (IFNs) and interleukins
(ILs) occurred in the same microenvironments. Consistent with
this, the M1 phenotype is simulated in vitro by the combined
action of PAMPs acting through Toll-like receptors (TLRs) and
IFNγ (8), with some evidence for synergy. Mechanisms under-
lying synergy include the ability of IFNγ to prime responses to
PAMPs by inducing expression of TLRs and their co-activators (9).
Synergy also results from the combined activation of differing sig-
naling pathways for TLRs through nuclear factor-κB (NF-κB) (9)
and IFNγ through signal transducer and activator of transcription
(STAT-1) (10).
The actions of IFNγ have led to the hypothesis that Thelper1
(Th1)-lymphocytes may be essential for, or at least prominent
contributors to, M1 polarization in vivo, a concept that has been
acknowledged in papers dealing with atherosclerosis (11–13). It is
consistent with studies showing that knockout (KO) of IFNγ and
its receptors reduces atherosclerosis progression (3), although the
impact on M1 polarization was not measured directly in any of
these IFNγ KO investigations. On the other hand, it is well rec-
ognized that other cytokines and combinations of cytokines that
activate the pathways leading to M1 states could bypass the require-
ment for IFNγ (9, 14). Conversely, macrophages can polarized to
a variety of alternatively activated or M2 states. The so-called M2a
phenotype occurs after treatment with IL-4 or IL-13, which are
potentially produced by Thelper2 (Th2) lymphocytes (15). Over-
all, this leads to the idea that T-lymphocytes, and, by implication,
adaptive immunity play an essential part in M1/M2 macrophage
polarization in atherosclerotic plaques. On the other hand, data
from other areas of inflammation support the conclusion that
M1/M2 polarization is primarily a function of innate immunity
and that lymphocytes play a minor, at best modulatory role (16).
Resolving this controversy is important for human atherosclerosis
since a variety of immunotherapies have been proposed and some
have already entered clinical trials (17).
Our present aim was formally to test the requirement for T and
B lymphocytes in M1 and M2 macrophage activation and MMP
production using an established ApoE-KO mouse model of ath-
erosclerosis formation. To do this, we compared the expression of
M1 and M2 markers, MMPs and the endogenous tissue inhibitors
of MMPs (TIMPs) in foam cell macrophages (FCMs) from subcu-
taneous granulomas and atherosclerotic plaques in ApoE KO and
ApoE/Rag-1 double-knockout (DKO) mice, which lack all T and
B lymphocytes. As it is already known that there are differences
in inflammation and plaque development between genders (18,
19), we used both male and female mice in this study. The mice
were fed on a high-fat diet because it was previously shown that
these conditions produced similar sized plaques in both genotypes
(20). Hence, we could be sure that measurements of the prevalence
of macrophages phenotypes would not be an artifact of different
stages of atherosclerosis progression or plaque sizes.
MATERIALS AND METHODS
BONE MARROWMONOCYTE ISOLATION AND DIFFERENTIATION TO
BONE MARROW-DERIVED MACROPHAGES
Mouse femurs and tibias were excised from C57BL/6 mice (Charles
River, UK) on a normal diet. The bone ends were cut and bone
marrow was flushed out with sterile phosphate-buffered saline
(PBS). Erythrocytes were removed using ACK lysis buffer (Life
Technologies, UK) and the pelleted white blood cells resuspended
in PBS and counted, giving an average yield of 40× 106 cells per
mouse. Cells were plated into 24-well plates at 0.5× 106 cells/well
and grown in RPMI 1640 media (Life Technologies) supplemented
with antibiotics, glutamine, and 20% fetal calf serum (FCS) (Life
Technologies) in the presence of 20 ng/ml recombinant human
macrophage colony-stimulating factor (M-CSF, R&D Systems,
USA). The media was changed every 3–4 days. After 7–10 days,
when the cells had differentiated into macrophages, M-CSF was
removed and the cells exposed to selected cytokines for 18 h in
serum-free media (SFM), as specified in the text. These included
mouse (m) IFNγ at 20 ng/ml (Miltenyi Biotec, USA), human
(h) tissue necrosis factor (TNF)-α at 10 ng/ml (R&D Systems,
USA), mIL-4 at 10 ng/ml (PreproTech, UK), and lipopolysac-
charide (LPS) at 10 ng/ml (Sigma-Aldrich, USA, L2654). Human
cytokines were used only when their efficacy on mouse cells had
been previously documented by the suppliers.
PERIPHERAL BLOOD MONONUCLEAR CELL ISOLATION AND
DIFFERENTIATION
Pooled peripheral blood was collected by cardiac puncture from
C57BL/6 mice with heparin as anti-coagulant. Monocytes were
then isolated density gradient separation on Ficoll Paque Plus and
differentiated to macrophages as previously described (21).
RNA EXTRACTION, REVERSE TRANSCRIPTION, AND QUANTITATIVE PCR
RNA lysates from cultured macrophages were collected using RLT
solution (Qiagen Ltd, UK) with β-mercaptoethanol and the total
RNA extracted using the Qiagen RNeasy kit (Qiagen Ltd), accord-
ing to the manufacturer’s instructions. The quantity and quality
of resulting RNA was assessed using a NanoDrop ND-1000 spec-
trophotometer (LabTech International, UK). Samples of cDNA
were generated using QuantiTect Reverse Transcription Kit (Qia-
gen Ltd), according to the manufacturer’s instructions and the
resulting cDNA was diluted 1:1 in 10 mM TrisHCl, pH 8.0. Real
time quantitative PCR was performed in a Roche Light Cycler 1.5
(Roche, UK) to quantify the steady-state concentration of RNA,
using the QuantiTect SYBR Green PCR Kit (Qiagen Ltd). The
primers used are listed in Table 1. Each reaction contained 2.5–7 ng
RNA and 0.5µM primers. Initial denaturation (15 min at 95°C)
was followed by 55 cycles of denaturation (15 s at 95°C), annealing
(20 s at 60°C), and extension (25 s at 72°C). Copy numbers of gene
transcripts per total nanogram RNA input were calculated using
standard curves constructed as recommended by from purified
amplicon (Bioline, USA).
IN VIVO STUDIES
Rag-1 KO mice that do not produce mature T or B cells (B6.129S7-
Rag-1tm1Mom/J) and ApoE KO mice on a C57BL/6 background
(B6.129P2-Apoetm1Unc/J) were purchased from The Jackson Labo-
ratories (USA), and bred together to create ApoE±/Rag-1± mice.
Breeding stocks of ApoE KO and ApoE/Rag-1 DKO mice were
obtained by crossing the resulting F1 generation. Mice were kept
in scantainers and given sterile food and water ad libitum. All
animal work was in accordance with the Home Office Guidance
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Table 1 | Primer sequences used for quantitative RT-PCR.
Gene Primer sequence
ARG-1 AGTCTGGCAGTTGGAAGCATCTCT
TTCCTTCAGGAGAAAGGACACAGG
COX-2 ATACTGGAAGCCGAGCACCTTTGG
ATGGTGGCTGTTTTGGTAGGCTGT
CD206 CCATTTATCATTCCCTCAGCAAGC
AAATGTCACTGGGGTTCCATCACT
FIZZ1 AGAGGTGGAGAACCCAGCTTTGAT
TTTCAAGAAGCAGGGTAAATGGGCA
IL-12p35 CCACAACAAGAGGGAGCTGCCTGCCC
AGTGCTGCGTTGATGGCCTGGAACT
IL-12p40 AGACCAGGCAGCTCGCAGCAAAGCA
GACACATCCCACTCCCACGCTGCC
iNOS CTCATGACATCGACCAGAAGCGT
TATATTGCTGTGGCTCCCATGTTG
MMP-2 GGCTGACATCATGATCAACTTTGG
GCCATCAGCCGTTCCCATACTTTAC
MMP-3 GCATCCCCTGATGTCCTCGTGG
TCCCCGGAGGGTGCTGACTG
MMP-8 TGCCTCGATGTGGAGTGCCTGA
GCCCTTGACAGCTGTGGCGT
MMP-9 AGAGAGGAGTCTGGGGTCTGGTTT
GAGAACACCACCGAGCTATCCACT
MMP-12 AATTACACTCCGGACATGAAGCGT
GGCTAGTGTACCACCTTTGCCATC
MMP-13 ATGATGATGAAACCTGGACAAGCA
ATAGGGCTGGGTCACACTTCTCTG
MMP-14 ACCACAAGGACTTTGCCTCTGAAG
CACCGAGCTGTGAGATTCCCTTGA
MMP-19 GATGAACTGGCCAGAACTGACCTT
GTCCCCGGTTGATGAGTTAGTGTC
MMP-23 CAAGGTTGGTGAGAGAGGGTAGGA
AGGAGTAGGTGCTGAGAACACGCT
MMP-25 CTCTGAGTGGCAGTGTTTGGAAGA
TGATGTCAGGCTCCTGGTACTGAG
TIMP-1 AGGAACGAAATTTGCACATCAGT
CAAAGTGACGGCTCTGGTAGTCCT
TIMP-2 GACTCCCCCTCAGACTCTCCCTAC
CATATTGATACCACCGCACAGGAA
TIMP-3 CACATCAAGGTGCCATTCAGGTAG
GTTCTCTCCTCCTCAACCCAAACA
Ym1 CAGGTCTGGCAATTCTTCTG
GTCTTGCTCATGTGTGTAAGTG
on the operation of the Animals (Scientific Procedures) Act 1986
and conforms to the Guide for the Care and Use of Labora-
tory Animals published by the US National Institutes of Health
(NIH Publication No. 85–23, revised 1996). Genotyping of the
mice was performed on ear or tail pieces, using the Direct PCR
kit (Bioquote, UK or Viagen Biotech, USA) after a Proteinase K
digestion (Sigma, UK). PCR was performed using Crimson Taq
Pol (New England Biolabs, UK), with dNTPs from Bioline (UK),
using primers designed by The Jackson Laboratories. Male and
female mice commenced a sterile high-fat diet (21–23% fat, Special
Diet Services, UK) at 5 weeks of age, and were sacrificed with an
anesthetic overdose 12 weeks later. Blood was taken via cardiac
puncture and heparinized plasma was subsequently analyzed for
total, HDL, and LDL/VLDL cholesterol (Cholesterol/Cholesterol
Ester Quantification Kit, Abcam, UK), after a minor adaptation
of the manufacturer’s instructions. The levels of selected M1 and
M2 cytokines was assessed in additional samples of mouse plasma
using a Bio-Plex Pro Mouse Cytokine Th1/Th2 Panel 8-plex (Bio-
Rad, USA). After the cardiac puncture, fresh tissue samples were
taken (tail tip, spleen, liver lobe) and the animals perfused via
the heart with PBS, then 10% formalin, at a constant pressure of
100 mmHg, with outflow through the left jugular vein. The bra-
chiocephalic artery (BCA) (with a small piece of aortic arch), heart
and remaining ascending and descending aorta were cleaned and
removed from each mouse. Other tissues harvested included thy-
mus and remaining liver. Tissue blocks of spleen less than 0.5 cm
thick were post-fixed in 10% formalin for 24 h for subsequent
histological examination, as described below.
SPONGE IMPLANTATION AND FOAM CELL MACROPHAGE ISOLATION
ApoE KO or DKO mice were fed the same high-fat diet as above
from 6 weeks of age. Two weeks later these mice had 0.5 cm3 sterile
polyurethane sponges containing ~50µl of Matrigel (VWR, UK)
placed under the dorsal skin under halothane anesthesia to gen-
erate FCMs as described previously (22, 23). The mice were fed
the high-fat diet for a further 4 weeks. Recovered sponges were
either fixed and embedded for immunohistological examinations
as described below or the FCM were isolated and studied ex vivo.
Fresh sponges were treated with 0.75 ml undiluted Dispase (VWR,
UK or BD Biosciences, USA) and then squeezed to obtain a cellular
exudate. FCM were then purified, as previously described (22, 24)
by flotation after centrifugation on a metrizamide gradient (1.3507
refractive index, Sigma) followed by differential adherence. Only
foam cells (validated by Oil-red-O staining) float because of the
relatively low buoyant density of lipid.
Samples were taken from each preparation immediately for
protein or RNA isolation, and mRNA levels quantified as described
above. Other cell preparations were cultured for a short period, to
allow adherence to coverslips. Oil-Red-O (2% Oil-red-O in iso-
propanol; Sigma) staining was performed to confirm lipid content,
and immunocytochemistry performed to confirm cell purity. Cells
were also assessed for their proliferative capacity [BrdU (Sigma)
incorporation, 8 h pulse] or in situ zymography (25). In this assay,
the gelatinolytic capacity of the macrophages isolated from the
sponges was determined using the EnzChek gelatinase/collagenase
assay kit (Invitrogen, USA). Controls included cells treated with
EDTA, 1,10-phrenanthroline (Sigma) or GM6001 (Millipore, UK),
to prevent MMP activity. Cells were fixed in paraformaldehyde
and mounted in Vectorshield+DAPI (Vector Labs, USA). Several
fields were photographed on each coverslip and the proportion of
cells with gelatinase activity as indicated by the loss of fluorescence
of the DQ-gelatin substrate determined.
HISTOLOGICAL METHODS
The proximal aorta and BCA from each mouse were embedded
in paraffin and 3µm sections cut at 3µm intervals from the
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atherosclerosis-prone areas of these vascular beds, as described
previously (23, 26). The first section after the bifurcation of the
BCA from the aorta was cleared and rehydrated and then stained
using Miller’s elastin/van Gieson (EVG) and plaque dimensions
were measured using image analysis software (Image Pro, Data-
Cell, Maidenhead, UK), as described previously (23). The aortic
sinus from each mouse was treated and examined in a similar
fashion, with the first leaflet section (from the aorta) stained
using EVG, with subsequent image analysis being performed (26).
For immunohistochemistry, 3µm sections were brought to water
and antigen retrieval performed using citrate buffer. Non-specific
binding blocked with 10% goat serum (Sigma) in PBS. Primary
antibodies for SMC (α-smooth muscle actin), macrophages [Grif-
fonia simplicifolia Lectin II (GSL)], iNOS, COX-2, CD206, arg-1,
Ym-1, MMP-12, MMP-13, MMP-14, and TIMP-3 (see Table 2)
were added to the sections and incubated either overnight at
4°C or for 1 h at room temperature. After washing and fur-
ther incubations with goat anti-rabbit-biotin (Dako or Sigma)
and ExtrAvidin-HRP (Sigma) staining was visualized using 3,3’-
diaminobenzidine (DAB, Sigma). A negative control where the
primary antibody was replaced with the relevant species IgG at
the same dilution was always included. The percentage of the
Table 2 | Primary and secondary antibodies and Griffonia simplicifolia
Lectin II.
Catalog
number
Type Supplier
Primary
GSL II B1215 Lectin Vector labs
α-Smooth muscle actin M0851 M_Mab Dako
arginase 1 sc-20150 Rb_PAb Santa Cruz
BrdU B2531 M_Mab Sigma
COX2 ab15191 Rb_PAb Abcam
iNOS ab15323 Rb_PAb Abcam
MOMA-2 ab33451 R_Mab Abcam
MMP-12 ab52897 Rb_MAb Abcam
MMP-13 ab39012 Rb_PAb Abcam
MMP-14 ab51074 Rb_MAb Abcam
STAT1p (phospho Y701) ab30645 Rb_PAb Abcam
STAT6p (phospho Tyr641) 06–937 Rb_PAb Millipore
TIMP-3 Ab39206 Rb_PAb Abcam
Ym1/2 01404 Rb_PAb Stemcell
Technologies
rabbit IgG negative control I5006 Sigma
mouse IgG2a negative
control
M5409 Sigma
Goat serum G9023 Sigma
Rabbit serum R9133 Sigma
Secondary antibody
GtαM E0433 Biotinylated Dako
GtαM B6649 Biotinylated Sigma
GtαRb E0432 Biotinylated Dako
GtαRb B6649 Biotinylated Sigma
RbαR E0468 Biotinylated Dako
plaque area stained with each cell-specific or phenotypic marker
or MMP/TIMPs antibody was determined using the same image
analysis software detailed above. The number of buried layers was
assessed manually on sections stained with EVG and on sections
using antibodies that recognize SMC. Paraffin-embedded sponge
sections were treated similarly, and the presence of markers of
macrophage activation examined. Oil-Red-O staining was per-
formed en face, and the percentage of fatty deposits in each aorta
was measured using NIH ImageJ v1.43.
STATISTICAL METHODS
All analyses were performed using GraphPad InStat v3.05 (Graph-
Pad Software, Inc. USA) or SPSS v21 (IBM, USA) software. Data
were checked for normality (Kolmogorov and Smirnov normality
test), and logarithmic transformation of data performed if neces-
sary. Regression analyses were performed using Pearson’s correla-
tion co-efficient. Statistical analyses of data were performed using
Students t -test, a Mann–Whitney U -test or 1- or 2-way ANOVAs,
with the 1-way ANOVA followed by a Bonferroni or Tukey-Kramer
post-test. Data are expressed as arithmetic mean± SEM or geo-
metric mean and 95% confidence limits, and statistical significance
defined as P < 0.05.
RESULTS
IN VITRO STUDIES IN MOUSE BONE MARROWMACROPHAGES
Bone marrow proved a convenient source of large quantities of
mouse monocytes that were converted to bone marrow-derived
macrophages (BMDM) using M-CSF. BMDM were 97% F4/80
and CD11b double positive by flow cytometry (results not shown).
We used mRNA expression for established M1 and M2 marker
genes as positive controls for classic or alternatively activation. As
expected from previous literature (15), classical activation with
LPS alone or LPS plus IFNγ increased mRNA levels of inducible
NO synthase (iNOS, NOS-2) and cyclooxygenase-2 (COX-2)
(Figure 1A), whereas alternative activation with IL-4 increased
mRNA expression of arginase-I (arg-1), Ym-1, and CD206. We
then investigated the concomitant regulation of a wide spectrum of
MMPs and TIMPs, many of which have been previously implicated
in atherosclerosis (27). The most abundant mRNAs under unstim-
ulated conditions were MMP-12>MMP-8=MMP-19=MMP-
14=TIMP-2> other MMPs and TIMPs (Figure 1B). Among the
MMPs studied, MMP-13 showed the most dramatic 121-fold stim-
ulation by LPS+ IFNγ (Figure 1B, note the scale is logarithmic).
LPS+ IFNγ treatment also increased expressions of MMP-14
(11.3-fold) and MMP-25 (14.6-fold); and decreased expressions
of MMP-19 (4.5-fold) and TIMP-2 (9.0-fold) (Figure 1B). Clas-
sical activation with a different mediator, tumor necrosis factorα
(TNFα), significantly increased expressions of MMP-2 (77-fold),
MMP-9 (3.5-fold), and MMP-14 (3.5-fold) but not of MMP-13
(Figure 1B). Classical activation with TNFα also increased MMP-
9 and MMP-14 expression in blood derived macrophages, similar
to BMDM, but did not affect any of the other MMPs or TIMPs
(results not shown). Treatment with IFNγ did not increase mRNA
levels of any MMP or TIMP in BMDM either alone or in the pres-
ence of LPS (Figures 1C,D). No effect of IFNγ was observed in
blood derived macrophages either (results not shown). Alternative
activation with IL-4 increased mRNA expression of only MMP-19
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FIGURE 1 | Continued
www.frontiersin.org October 2014 | Volume 5 | Article 537 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hayes et al. Foamy macrophage activation without lymphocytes
FIGURE 1 | Continued
Effect of M1/M2 polarization on mRNAs for markers, MMPs, and
TIMPs in mouse bone marrow-derived macrophages. Monocytes
from mouse bone marrow were differentiated to macrophages in M-CSF
and then treated with bacterial lipopolysaccharide (LPS), interferon-γ
(IFNγ), tumor necrosis factor-α (TNFα), or interleukin-4 (IL-4) alone or in
combination, as indicated. SFM= serum-free medium. (A) The effect of
polarization by IFNγ, LPS, LPS+ IFNγ, or IL-4 on M1/M2 markers
(n=4–5). (B) The effect of polarization by IFNγ+ LPS, TNFα, or IL-4 on
MMPs and TIMPs (n=3–8). (C) Effect of IFNγ alone on macrophages
incubated in SFM. (D) Effect of IFNγ on macrophages incubated in SFM
containing LPS. Values are expressed as mean and SEM (A) or mean and
95% confidence intervals (B–D). *M1 different from M0, #M2 different
from M0, P < 0.05.
Table 3 | Concentration of inflammatory and anti-inflammatory cytokines in plasma from ApoE KO or ApoE/Rag1 KO mice.
Male ApoE KO Male DKO P-value (males) Female ApoE KO Female DKO P-value (females)
Mean SEM Mean SEM Mean SEM Mean SEM
IFNγ 11.88 4.353 5.680 2.902 0.2440 11.33 6.345 6.012 2.595 0.6275
TNFα 297.4a 56.00 206.3 23.16 0.1495 167.9 21.46 191.0 19.26 0.4331
GM-CSF 118.0 24.55 106.4 16.66 0.6959 72.85 11.24 113.6 13.22 0.0304
IL-12p70 133.6 38.79 129.9 37.60 0.9457 58.65 12.61 127.7 29.90 0.0302
IL-10 15.23 3.023 23.99 3.852 0.0964 10.32 3.0.03 25.38 2.486 0.0012
Concentrations (picograms per milliliter) are expressed as mean and SEM, n=9–10. Bold type indicates P<0.05 for ApoE KO vs. DKO.
aIndicates significant gender difference for that genotype.
Table 4 | Concentration of cholesterol-containing lipoproteins in plasma from ApoE KO or ApoE/Rag1 KO mice.
Male ApoE KO Male DKO P-value (males) Female ApoE KO Female DKO P-value (females)
Mean SEM Mean SEM Mean SEM Mean SEM
Total 1360a 116.5 1215a 47.04 0.3939 802.4 64.65 707.3 59.73 0.3050
HDL 58.64 32.99 108.0 21.20 0.2364 14.39 3.177 85.86 41.76 0.0022
LDL+VLDL 931.3a 71.77 508.4 99.79 0.0063 504.4 55.29 362.3 68.75 0.1384
Concentrations (milligrams per deciliter) are expressed as mean and SEM, n=6. Bold type indicates P< 0.05 for ApoE KO vs. DKO.
aIndicates significant gender difference for that genotype.
in BMDM (Figure 1B). These results revealed widely different
levels of expression and divergent patterns of regulation of MMPs
and TIMPs, which informed our choice of genes to measure in the
subsequent in vivo experiments (see below).
CIRCULATING INFLAMMATORY CYTOKINE AND CHOLESTEROL LEVELS
IN ApoE KO AND ApoE/Rag-1 DOUBLE-KNOCKOUT MICE
To investigate the impact of lymphocytes on M1/M2 polariza-
tion and MMP/TIMP expression, we compared ApoE KO and
ApoE/Rag-1 DKO mice, which were genotyped using PCR to ver-
ify the deletion of ApoE alone or ApoE and Rag-1. The weight
of the spleens of ApoE KO mice (115± 6 mg, n= 8) was reduced
to (56± 9 mg, n= 10) in DKO mice and histological analysis of
cut sections confirmed the absence of lymphocytes from DKO
spleens (not shown). As expected, the expression of CD3 mRNA
in the spleen, as a further marker of the presence of lympho-
cytes, was measurable in all ApoE KO mice tested (mean value
1.6± 0.5 copies/ng RNA, n= 10) but undetectable in all DKO mice
tested. We used blood levels of cytokines related to Th1 and Th2
lymphocytes to further characterize the inflammatory status of
ApoE KO and DKO mice. As in Table 3, circulating levels of IFNγ
were low and not different between genotypes, whereas IL-4 levels
were below the limits of detection of our assays. Of the more
abundant cytokines, TNFα levels were not different, whereas GM-
CSF, IL-12, and IL-10 levels were elevated (1.6, 2.2, and 2.5-fold,
respectively) in female DKO compared to ApoE KO mice. The
same trend was seen for IL-10 levels in male mice (Table 3). These
results showed, unexpectedly, that cytokines associated with M1
polarization (i.e., GM-CSF and IL-12) and M2 polarization (IL-
10) were at least the same or even elevated in DKO mice. We
also noted that TNF-α levels were significantly 1.8-fold higher in
male than female ApoE KO mice but not different in DKO mice
(Table 3).
Plasma cholesterol levels play a fundamental role in determin-
ing the extent of atherosclerosis in human beings and animal
models. As shown in Table 4, the plasma concentrations of total
cholesterol were not different between ApoE KO and DKO mice.
HDL cholesterol was significantly increased sixfold in female DKO
vs. ApoE KO mice and there was the same trend (1.9-fold) in
the male mice. Conversely, LDL plus VLDL concentrations were
significantly 1.8-fold lower in male DKO than ApoE KO mice
and same trend (1.4-fold) was seen for the females. We noted
that total cholesterol levels were significantly higher in males
than females of either genotype. Furthermore, VLDL+ LDL levels
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were significantly higher in the male than female ApoE KO mice
(Table 4). Based on increased HDL and decreased VLDL+ LDL,
DKO mice of either gender might be expected to be protected from
atherosclerosis compared with ApoE KO mice.
M1/M2 MARKER AND MMP mRNA LEVELS IN GRANULOMA FCMs
FROM SUBCUTANEOUS SPONGES
We sought a ready source of foam cells generated in vivo to
investigate expression of the M1/M2 markers and MMPs and
TIMPs measured in our in vitro study of non-foamy macrophages.
Atherosclerotic plaques are small and difficult to disrupt but
hypercholesterolemia promotes the accumulation of foam cells
at several more accessible sites in human beings and mice. For
example, foam cells accumulate in the peritoneum (28) or in gran-
ulomas that form in sterile sponges implanted subcutaneously into
atherosclerosis-prone mice (23). In this study, FCMs were isolated
from subcutaneous granulomas. They were purified based on their
decreased buoyant density by flotation over a density gradient.
The yield of foam cells from subcutaneous sponges implanted for
6 weeks into ApoE KO or DKO mice was 4.07± 0.61× 106 and
5.87± 1.21× 106 cells, respectively, and did not significantly vary
between genders. Foam cells from ApoE KO mice were 95.5± 1.6%
macrophages (using MOMA-2 as a marker). FCMs had detectable
levels of the same M1 and M2 markers seen in non-foamy BMDM,
irrespective of whether they came from ApoE KO or DKO mice
(Table 5). We concluded that FCMs acquired M1 marker genes
in the absence of T and B lymphocytes. Indeed, there was a trend
toward higher levels of mRNA expression of M1 markers, iNOS
and COX-2, in DKO animals, although this was not significant
(Table 5). Given this somewhat surprising conclusion, we mea-
sured additional M1 markers, namely IL-12 p35 and p40 and
SOCS3, which were also detectable and showed no significant dif-
ference between ApoE-KO and DKO mice (Table 5). The mRNAs
for M2 markers arg-1, and Ym-1 were also expressed at similar
levels in granuloma FCMs from ApoE KO or DKO mice (Table 5),
whereas CD206 was slightly elevated in male DKO compared to
ApoE KO mice. The data suggested that M2 polarization also
occurred efficiently in the absence of lymphocytes. To confirm this,
we added measurements of FIZZ1 and IL-10, which also showed
no difference between ApoE KO and DKO FCMs (Table 5). We
noted a few significant gender differences. The mRNA levels of
the M1 marker, IL-12p40, and the M2 markers, CD206 and Ym-1,
were approximately 50% lower in granuloma FCMs from male
compared to female ApoE KO mice.
The MMPs that were increased by classical activation in blood
or BMDM, that is MMP-2, MMP-9, MMP-13, MMP-14, and
MMP-25, were all expressed in granuloma FCMs, irrespective of
Rag-1 genotype (Table 5). TIMP-2 (that was decreased by classical
activation) and MMP-19 (that was decreased by classical activa-
tion and increased by alternative activation) were also expressed
Table 5 | Characteristics of foam cell macrophages obtained from subcutaneous sponges.
Male KO Male DKO P-value (males) Female ApoE Female DKO P-value (females)
Mean SEM Mean SEM Mean SEM Mean SEM
COX2 915 135 2053 729 0.3692 931 134 1306 243 0.1981
iNOS 56 7 474 305 0.3793 69 13 331 242 0.3357
IL-12p35 1085 88 904 130 0.2451 1563 299 1154 276 0.3316
IL-12p40 6a 1 9 3 0.7304 13 2 11 4 0.6432
SOCS3 1797a 204 4117 1060 0.1191 2679 327 3038 587 0.5896
Arg-1 79646 5095 87511 7825 0.3953 87172 14259 90946 10539 0.8345
CD206 1317a 198 2150 285 0.0224 2420 212 2293 372 0.7707
FIZZ1 377 58 518 82 0.1640 365 65 594 136 0.2810
IL-10 10262 1115 10234a 780 0.9852 12984 2289 19852 4366 0.1853
Ym-1 35a 5 78 31 0.3311 103 20 124 29 0.5530
MMP2 387 77 614 136 0.1462 535 97 681 173 0.4586
MMP9 104a 18 217 63 0.0720 182 22 155 14 0.3537
MMP12 176264 11743 150381 15260 0.1860 215896 28916 160661 26809 0.1831
MMP13 43800 3821 33103 3990 0.0664 48821 8573 34538 4202 0.1770
MMP14 4888 570 5402 462 0.4963 5214 917 5856 942 0.6332
MMP19 8486 1684 7893 930 0.7723 8756 998 7814 1268 0.5699
MMP25 23 3 112 47 0.6049 27 6 84 42 0.9307
TIMP-1 1674a 237 2321 399 0.1625 2543 330 1771 401 0.1571
TIMP-2 6624a 533 6984 730 0.6884 10456 682 6455 606 0.0008
TIMP-3 1203a 160 2728 689 0.0352 2228 356 2452 586 0.7434
FCMs were isolated by density gradient centrifugation and differential adhesion from sponges implanted under the skin of ApoE KO or ApoE/Rag-1 DKO mice, as
indicated. Levels of mRNAs of M1/M2 markers and MMPs/TIMPs are expressed as copies/ng total RNA (mean and SEM, n=7–13). Bold type indicates P<0.05 for
ApoE KO vs DKO.
aIndicates significant gender difference for that genotype.
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at high levels in both genotypes (Table 5). Female ApoE KO mice
had 1.6-fold more TIMP-2 mRNA than the corresponding males.
MMP-12 and TIMP-1 [that showed no relationship with clas-
sical/alternative phenotype under the conditions of our in vitro
studies (Figure 1B)] were expressed irrespective of genotype, but
TIMP-3 was significantly increased 2.3-fold in male DKO com-
pared to ApoE KO mice. The proportion of granuloma FCMs
able to degrade gelatin was determined using in situ zymogra-
phy. A significantly higher percentage of granuloma FCMs had
gelatinase activity from female DKO (91%) compared with ApoE
KO animals (76%), and the same trend was evident in the in the
males (86 vs. 74%) (Figure 2A), Pooling the data, the 88% of
the DKO mice had gelatinase activity compared to 75% in the
ApoE KO mice (P = 0.0026). The proliferative capacity of FCMs
was assessed by measuring BrdU incorporation (Figure 2B). Pro-
liferation was not different in male mice of either genotype but
was increased almost twofold in female ApoE KO mice compared
to DKO mice (P < 0.0001). Migration through a matrigel layer
in a modified Boyden chamber assay (n= 3–5) was not signifi-
cantly different amongst granuloma FCMs from the two genotypes
(results not shown).
M1/M2 MARKER PROTEIN EXPRESSION AND PATHWAY ACTIVATION IN
GRANULOMA FCMs FROM SUBCUTANEOUS SPONGES
We used immunohistochemistry to confirm the protein expres-
sion of M1 and M2 markers in vivo by using sections taken
from excised subcutaneous sponges. A subpopulation of granu-
loma cells in sponge sections stained for iNOS (Figures 3A,B) or
COX-2 protein (Figures 3C,D) in either Rag-1 genotype. Control
sections stained with isotype matched non-immune immunoglob-
ulins had no staining (Figures 3E,F). Furthermore, a fraction of
the granuloma cells in sponge sections stained for nuclear localized
NF-κB (Figures 4A,B) or phosphorylated STAT-1 (Figures 4C,D),
indicating that these cells had undergone activation of the sig-
naling pathways that are associated with M1 activation. Sections
stained with isotype matched non-immune immunoglobulins had
no staining (Figures 4E,F). Some FCMs in sections also stained for
arg-1 (Figures 5A,B), Ym-1 (Figures 5C,D), or phosphorylated
STAT-6 (Figures 5E,F), demonstrating the presence of marker
proteins and active signaling pathways that are associated with
M2 macrophages. Sections stained with isotype matched non-
immune immunoglobulins again had no staining (Figures 5G,H).
Similar results to those with sponge sections were found by
immunocytochemistry of FCM isolated from sponges (data not
shown).
PLAQUE SIZE, COMPOSITION, M1/M2 MARKERS, AND MMP PROTEIN
EXPRESSION IN FCMs IN ATHEROSCLEROTIC PLAQUES FROM ApoE KO
AND DKO MICE
Plaques in the aortic sinus tended to be smaller in DKO compared
with ApoE KO mice but this did not reach statistical significance
(Figure 6A). However, in agreement with previous reports (18,
19), significant gender differences were observed (Figures 6A,B).
Aortic sinus plaques were significantly bigger in females com-
pared with males in ApoE KO (twofold: P = 0.0057) and DKO
(2.5-fold: P = 0.0043) mice. Plaques in the BCA were 2.1 times
smaller in the DKO compared to ApoE KO males (P = 0.004)
but there was no significant difference between the two geno-
types in the females (Figure 6B). Interestingly,ApoE KO males had
2.9 times larger plaques when compared with ApoE KO females
(P < 0.0001) (Figure 6B), which was the opposite of the relation-
ship observed in the aortic sinus. This difference has also been
noted before (29). These differences reinforced our decision to
stratify our data by gender.
Buried fibrous layers in BCA plaques have been suggested as
a marker of plaque complexity or instability (30). However, we
observed no linear regression between the number of buried lay-
ers and plaque size (P-values range from 0.20 to 0.68, n= 15–17) or
macrophage content (P-values range from 0.29 to 0.99,n= 15–17),
which are other measures that have been associated with plaque
vulnerability. In any event, there were no significant differences in
the number of buried layers in plaques from DKO compared to
ApoE KO mice (Figure 6C). The area occupied by plaques in the
aorta (as demonstrated by en face staining with Oil-Red-O) gives
another measure of the extent of plaque progression in these mice.
This did not change with phenotype or gender (Figure 6D).
The comparable plaque size in the aortic root of ApoE KO and
DKO mice has been reported previously (20), and was consistent
FIGURE 2 | Characteristics of foam cell macrophages (FCMs) obtained
from subcutaneous granulomas. Granuloma FCMs were isolated by
flotation over a density gradient and differential adhesion from sponges
implanted under the skin of ApoE KO or ApoE/Rag-1 DKO mice, as
indicated. (A) In situ zymography (gelatinase activity, mean and SEM,
n= 9–13). (B) Proliferative capacity (8 h BrdU pulse, mean and SEM,
n= 8–14). *P < 0.05 vs. DKO, $P <0.05 indicates gender differences for
that genotype.
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FIGURE 3 | M1 marker staining of sponge sections from ApoE KO or
ApoE/Rag-1 DKO mice. Sections from ApoE KO (A,C,E) or DKO mice
(B,D,F) were stained to show immunolocalization of inducible nitric oxide
synthase (iNOS) (A,B) or cyclooxygenase-2 (COX-2) (C,D). Control sections
(E,F) were exposed to non-immune IgG. Positive staining appears brown
(DAB), nuclei blue-purple (hematoxylin), and sponge spicules light blue.
Sections from either mouse strain could contain cells with positive
cytoplasmic staining (arrowheads). Some cells did not stain, and some
appeared to have COX-2 in their nucleus (arrows) (Magnification: ×600).
with the objective of our experimental design. It ensured that any
difference in foam cell phenotype in the aortic sinus would be
independent of plaque size. However, the larger plaque size in
male BCA plaques in ApoE KO than DKO mice could complicate
the interpretation of data relating to phenotypes in these mice.
FIGURE 4 | Signal pathway activation in sponge granuloma sections
from ApoE KO or ApoE/Rag-1 DKO mice. Sections from ApoE KO
(A,C,E) or DKO (B,D,F) mice were stained to show immunolocalization of
NF-κB (A,B) or phosphorylated STAT1 (C,D). Control sections (E,F) were
exposed to non-immune IgG. Positive staining appears brown (DAB), nuclei
blue-purple (hematoxylin), and sponge spicules light blue. Sections from
either mouse strain contained many cells with positive cytoplasmic staining
(arrowheads). Some cells did not contain detectable levels of NF-κB or
phospho-STAT-1, while others appeared to have NF-κB or phospho-STAT-1
present in their nucleus (arrows) (Magnification: ×600).
Immunohistochemistry for α-smooth-muscle-cell-actin (α-
SM-actin) was used to quantify the presence of vascular SMC
and staining for GSL to quantify macrophages. As expected
SMC were mainly found in the media and fibrous cap of
plaques (Figures 7A–D). Most GSL positive had a foamy
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FIGURE 5 | M2 marker staining and signal pathway activity in
sponge granuloma sections from ApoE KO or ApoE/Rag-1 DKO
mice. Sections from ApoE KO (A,C,E) or DKO (B,D,F) mice were stained
to show immunolocalization of arginase-1 (A,B), Ym-1 (C,D), or
phosphorylated STAT6 (E,F). Control sections from ApoE KO (G) or DKO
(H) mice were exposed to non-immune IgG. Positive staining appears
brown (DAB), nuclei blue-purple (hematoxylin), and sponge spicules light
blue. Sections from either mouse strain contained cells with positive
cytoplasmic staining (arrowheads), but some cells did not contain
detectible levels of arginase-1, Ym-1, or phospho-STAT-6. Some cells
were observed with nuclear phospho-STAT-6 staining (arrows)
(Magnification: ×600).
appearance on close examination and were therefore mainly FCMs
(Figures 7A–D). However, some medial cells, presumably syn-
thetic state SMC or SMC transdifferentiating toward macrophages
(31) also stained with GSL (Figures 7A–D). Given the small size
of atherosclerotic plaques in the AS and BCA, it was impracti-
cal to extract mRNA for qRT-PCR, or total protein for West-
ern blotting. We therefore used immunohistological methods
to quantify the presence of M1 and M2 markers as well as
selected MMPs and TIMP-3. Our in vitro studies together with
the availability of suitable antibodies (Table 2) guided our choice
of iNOS as suitable M1 marker and arg-1 and Ym-1 as suit-
able M2 markers. Based again on our in vitro studies and the
availability of suitable antibodies (Table 2), we chose to study
MMP-13 and MMP-14 as potentially related to classical acti-
vation. MMP-12 and TIMP-3 were also chosen for compari-
son because they are abundantly expressed in vitro, irrespective
of classical and alternative activation. For each of the antibod-
ies and lectin used the staining was specific, both in the aortic
sinus (Figures 7A,B) and the BCA (Figures 7C,D) of either
genotype. Interestingly, phenotypic markers, MMPs and TIMP-3
were mainly associated with GSL-positive areas rather than α-
actin (Figures 7A–D). The percentage of the total plaque area
stained with each antibody was measured using image analy-
sis. By confining measurements to the plaque, we avoided any
influence of staining from the media layer. Furthermore, some
of the antibodies stained cardiac myocytes surrounding the aor-
tic root (Figures 7A,B) but this did not distort our subse-
quent measurements because these areas were excluded from the
quantification.
The area stained withα-SM actin in the aortic sinus (Figure 8A)
was less than 20% under all conditions, consistent with the lipid-
rich nature of plaques in this model at this time point. Neverthe-
less, SMC area was 1.5 times higher in the female DKO compared
with ApoE KO mice (P = 0.0051) and the same trend was seen in
the male mice. The pooled data for both genders were also signif-
icant (P = 0.0058) There were no differences between genotypes
in the BCA (Figure 8B), although male DKO mice had 3.8-times
more SMC staining than females (Figure 8B). Plaque areas stained
with GSL were 30–40% in AS or BCA, consistent with highly
inflamed nature of these plaques. GSL areas in the AS (Figure 8A)
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FIGURE 6 | Histological appearances of aortic sinus, brachiocephalic
artery and aortic plaques in ApoE KO and ApoE/Rag-1 DKO mice. (A) Area
of plaque in the aortic sinus. The first section showing leaflet of the aortic
valve was stained using Miller’s elastin/van Gieson (EVG) and the area of
plaque in each section calculated using computer aided planimetry,
n=16–22. (B) A section taken 3µm after the bifurcation of the
brachiocephalic artery (BCA) from the aorta was treated and stained and
examined in a similar fashion to A, n=13–19. (C) The number of buried layers
in plaque from BCA were assessed in EVG and α-SM-actin stained sections,
n=11–14. (D) Whole aorta were opened longitudinally and stained en face for
the presence of neutral lipid using Oil-Red-O. The area of lipid-rich plaque in
each aorta was calculated using computer aided planimetry, n=10–11. Values
are expressed mean and SEM. *P <0.05 vs. DKO, $P <0.05 indicates gender
differences for that genotype.
and BCA (Figure 8B) did not significantly differ in the two mouse
genotypes or genders.
Quantitative measurements of staining for iNOS, arg-1, or Ym-
1 showed that these areas were similar to or less extensive than
GSL (Figures 8A,B), consistent with the concept of their being
restricted to subpopulations of the GSL-positive cells (Figures 7A–
D). Approximately, the same proportion of cells stained for iNOS
and Ym-1, implying that approximately half of the FCMs had M1
or M2 markers, consistent with previous literature (12). Staining
for arg-1 was more extensive and appeared to overlap with that for
iNOS in some cells (Figures 7A–D and 8A,B). Staining for iNOS
tended to be higher in DKO than ApoE KO mice in the aortic sinus
(Figure 8A) and BCA (Figure 8B), although this was not signifi-
cant. Based on this evidence, M1 activation of plaque FCMs occurs
and may even be increased in the absence of T and B lymphocytes,
irrespective of gender, and consistent with the PCR data on granu-
loma FCMs described above. Female DKO mice had 1.4-fold more
arg-1 staining than ApoE KO mice in the aortic sinus (Figure 8A)
and the same trend was seen in the BCA (Figure 8B). There were
no differences in arg-1 staining for male DKO and ApoE KO mice
at either site (Figures 8A,B). Staining for Ym-1 was also not dif-
ferent between genotypes in the aortic sinus (Figure 8A) or BCA
(Figure 8B). Based on this evidence, M2 activation of FCM was
present in the absence of T and B lymphocytes in mice of both
sexes, and may be increased in the DKO females.
Additional gender differences were also noted. Staining for
iNOS in the aortic sinus was 2.4 times greater in the male than
female mice of both ApoE KO and DKO mice (Figure 8A). Staining
for arg-1 was 2.1 and 1.4-fold higher in male compared with female
ApoE and DKO mice, respectively in the aortic sinus (Figure 8A)
although not the BCA (Figure 8B). Staining for Ym-1 was similar
between males and females of either genotype in the aortic sinus,
and in ApoE KO in the BCA (Figures 8A,B).
The areas stained for MMPs-12, -13, -14, and TIMP-3 were
extensive in the aortic root and BCA plaques, which shows that
these proteins are widely expressed in plaques (Figures 8A,B).
The area of staining for MMP-13 and MMP-14 was similar in
ApoE KO and DKO mice of either gender in the AS (Figure 8A)
or BCA (Figure 8B). Clearly, the absence of T and B lym-
phocytes had little impact on extent of MMP-13 or MMP-14
staining, consistent with the PCR data obtained from granuloma
FCMs. MMP-12, however, showed fourfold increased staining in
male DKO compared to ApoE KO mice (P = 0.0261), although
this was not replicated in the BCA (Figure 8B) or in female
mice. The areas of TIMP-3 staining in the BCA were in all
cases similar irrespective of genotype or gender (Figures 8A,B).
Male mice of either genotype had approximately twice as much
staining for MMP-13, MMP-14, or TIMP-3 than females in the
AS (Figure 8A), although there was no difference in the BCA
(Figure 8B).
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FIGURE 7 | Immunohistochemical staining for cell type, M1 and M2
markers and for MMPs andTIMPs. Near consecutive sections to the section
stained with elastin/van Gieson (EVG) were subjected to
immunohistochemistry for macrophages [Griffonia simplicifolia lectin II (GSL)],
smooth muscle cells (α-smooth muscle actin; actin), iNOS, arg-1, Ym-1,
MMP-12, MMP-13, MMP-14, and TIMP-3, using the antibodies detailed in
Table 2. Controls were performed with non-immune IgG or normal serum
replacing the primary antibody. (A) Aortic sinus plaques from ApoE KO mice
(Magnification: ×4). (B) Aortic sinus plaques from ApoE/Rag1 DKO mice
(Magnification: ×4). (C) Brachiocephalic artery plaques from ApoE KO mice
(Magnification: ×10). (D) Brachiocephalic artery plaques from ApoE/Rag1
DKO mice (Magnification: ×10).
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FIGURE 8 |The proportion of staining for cell type, M1/M2 markers, MMPs, andTIMPs in plaques from ApoE KO or ApoE/Rag1 DKO mice. (A) Aortic
sinus plaques. (B) Brachiocephalic artery plaques. Values are expressed as mean and SEM. *P <0.05 vs. DKO, $P < 0.05 indicates gender differences for that
genotype, n=11–19.
DISCUSSION
The clear conclusion from our experiments is that FCMs in
subcutaneous granulomas and atherosclerotic plaques acquired
markers of classical (M1) and alternative (M2) activation even in
the absence of lymphocytes. This conclusion was valid in male
and female mice, despite differences in the size and composi-
tion of plaques between the two genders. Furthermore, since
nuclear localized NF-κB, phospho-STAT-1 and phospho-STAT-
6 were detected in granuloma FCMs, activators of the pathways
leading to M1 and M2 polarization also existed in adequate quan-
tities in the presence or absence of T or B lymphocytes. We also
observed that expression of several MMPs and TIMPs occurred
in granuloma and plaque FCMs in vivo independently of T and B
lymphocytes.
Recent work demonstrated that foam cell formation did not,
in itself, lead to M1 or M2 activation (28). By contrast, peritoneal
FCM generated in vivo were resistant to M1 activation, owing
to stimulation of the LXR pathway. Nevertheless, several studies
showed that there are FCMs in mouse atherosclerotic plaques that
express both M1 and M2 markers either in situ (12, 13) or after
collagenase isolation (32). M1 and M2 markers were associated
with distinct cell populations even though they had overlapping
distributions in the intima of advanced mouse plaques (32). Our
histological observations confirmed these findings but showed,
in addition, that FCMs produced in the context of the foreign
body reaction caused by a polyurethane sponge implantation
also prominently expressed M1 and M2 markers. Granuloma
FCMs mimicked the gene expression pattern of plaque FCMs
and may therefore be useful as a more-easily isolated surrogate.
Functionally, iNOS and arg-1 appear to compete for substrate.
Indeed, in a previous study, we demonstrated this directly in
rabbit FCMs where down-regulation of arg-1 compared to non-
foamy macrophages led to decreased urea and increased nitrate
release (24).
In previous papers dealing with atherosclerosis, it has been
acknowledged that Th1- and Th2-lymphocyte related cytokines
can polarize macrophages toward M1 and M2 phenotypes,
respectively (11–13). This suggests that lymphocytes and hence,
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by implication, adaptive immunity plays an essential role in
macrophage polarization, albeit in concert with other factors (11).
On the contrary, our new data show clearly that M1/M2 polariza-
tion of FCMs can take place efficiently in the absence of T and
B cells. To do this, we recreated a previously-characterized cross
(20) between the well-established ApoE KO mouse and the equally
well-characterized Rag1 KO mouse. We obtained similar develop-
ment of plaques in these mice as previously observed (20) and then
went on to make novel observations of macrophage phenotypes
in subcutaneous granulomas and plaques.
It is worth noting that the absolute copy numbers of the M1
and M2 marker mRNAs measured in granuloma FCMs were of
the same order of magnitude as those in measured in classical and
alternatively activated macrophages in vitro (compare Table 5 to
Figure 1A). Despite the obvious limitations of comparing data
across such different experimental conditions, it is hard to escape
the conclusion that the FCMs produced in vivo express M1 and M2
marker genes to a substantial degree, irrespective of the presence of
lymphocytes. Moreover, the canonical pathways of classical acti-
vation, NF-κB and STAT-1, and alternative activation, STAT-6, are
also triggered in T and B cell deficient mice. One possible expla-
nation is that TLR-4 mediated induction of so-called interferon
response factors (IRFs, specifically IRF-3 and IRF-7) can lead to
the secretion of IFNα and IFNβ, thereby bypassing the require-
ment for IFNγ (9). Plaques contain several potential activators of
TLRs (33); and these could well be the sources of classical activa-
tion. In addition to TLR agonists, other stimulators of the NF-κB
pathway, including TNFα and IL-1, that are known to occur in
mouse atherosclerotic plaques (3) could also act as classical acti-
vators independently of IFNγ, as shown in many previous studies
(3, 14). The presence of these alternative mediators therefore pro-
vides a rationale for M1 activation in T and B cell depleted mice,
although additional experiments beyond the present scope would
be needed to identify the specific mediators. M2 polarization can
also occur in response to a variety of mediators, although activa-
tion of STAT-6 appears to indicate the mediation of IL-4 and/or
IL-13 in our mice even in the absence of lymphocytes. An addi-
tional, non-exclusive explanation for our findings is that there are
sources other than lymphocytes for the cytokines associated with
M1 and M2 activation in mice. For example, natural killer cells
were shown to be an active source of IFNγ in Rag-1 KO mice (34)
and could therefore account for the residual levels of IFNγ we
observed in the blood of ApoE/Rag-1 DKO mice (Table 3). Like-
wise, mast cells (35) and neutrophils (36) are plausible sources of
IL-4 and IL-13 in lymphocyte-depleted mice.
MMPs have been strongly implicated in the progression of ath-
erosclerosis, and more particularly in ECM degradation as well
migration, proliferation and apoptosis of vascular cells (5, 37).
The results in Figure 1B showing that MMP-2, MMP-9, MMP-13,
MMP-14, and MMP-25 were up-regulated and TIMP-2 down-
regulated in mouse macrophages during classical activation are
consistent with previously reviewed data for MMP-9 and MMP-
13 (38). However, IFNγ had no effect on MMP or TIMP mRNA
expression in mouse macrophages at the 18-h time point we used
(Figures 1C,D), which was chosen to allow time for priming effects
to be observed. Up-regulation of MMP-19 and down-regulation
of MMP-14 were the only changes that we observed in response
to IL-4 (Figure 1B). Furthermore, there was no difference in the
expression level of any of the MMPs or TIMPs in FCMs isolated
from sponge granulomas in ApoE KO and DKO mice. Despite
this, there was a small increase in the proportion of cells able
to degrade gelatin in DKO mice, which might be explained by the
trend toward increases in MMP-2 and MMP-9 mRNA expressions.
Further experiments would be needed to verify this. Recent work
has placed increased emphasis on macrophage proliferation in
mouse atherosclerosis (39). Specifically, it has been suggested that
proliferation, rather than recruitment, is the major factor leading
to accumulation of FCMs into atherosclerotic plaques of ApoE
null mice at early time points (40). We found a relative decrease in
FCMs from female DKO mice, but this did not appear to be associ-
ated with differences in M1/M2 polarization or MMP expression.
Turning to our immunohistochemical studies of atherosclerotic
plaques, few changes were noted in the extent of MMP-12, -13,
-14, or TIMP-3 staining. Only MMP-12 staining appeared to be
increased in male DKO mice in the AS but not BCA. Since, we
found no effect of classical or alternative activation on MMP-12
expression in vitro, this isolated observation might be explained
by another mediator such as GM-CSF, which has been shown
to up-regulate MMP-12 in several, previously reviewed studies
(38). However, the plasma cytokine levels (Table 3) provide no
corroboration for this contention.
During the course of our studies, we noted significant differ-
ences in cytokine and lipid levels, plaque sizes, and content of SMC
between male and female mice that obliged us to consider these
data separately. We found smaller AS plaques in male than female
ApoE KO mice, similar to what has been previously noted and
attributed to the effects of estrogens (19) and prostaglandins (41).
On the other hand, we found that males develop larger lesions
in the BCA, confirming what we previously published in thesis
form (29) and consonant with findings in the aorta at longer time
points (18). This is most likely related, at least in part, to the higher
total cholesterol and VLDL+ LDL levels, we observed in male mice
(Table 4). The important fact to stress, however, is that acquisition
of M1 and M2 markers and expression of MMPs and TIMP was
independent of T and B lymphocytes, irrespective of the gender of
mice we analyzed.
Human atherosclerotic plaques also have prominent popula-
tions of FCMs that show M1 markers (42, 43) and have been
known for many years to have nuclear localized NF-κB (44). Con-
sistent with our present results, work on cells isolated from human
atherosclerotic plaques, placed emphasis on innate immune mech-
anisms, by showing that TLR-2 activation plays an important role
in M1 polarization and MMP secretion (45). There are also foci of
FCMs in the intima that express M2 markers, which are distinct
from FCMs carrying M1 markers (11). Non-foamy macrophages
carrying M2 markers are even more prevalent in the adventi-
tia (43). Hence, the distribution of cells carrying M2 markers in
human plaques appears to be more restricted than in the mouse
plaques in our study (Figures 7A–D) and in those previously
published (12, 13).
With respect to MMPs and TIMPs, comparison of our in vitro
results with published data from human macrophages isolated and
incubated under very similar conditions (38, 42, 46) demonstrates
many differences. For example, MMP-1 is absent but MMP-13
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is abundant in mouse macrophages, whereas MMP-13 is absent
and MMP-1 is abundant in human macrophages (42, 47), consis-
tent with the limited distribution of MMP-13 in human tissues
(48). Furthermore, MMP-12 is apparently much more abundant
in mouse macrophages (Figure 1B) than human macrophages
(42). Conversely, mRNAs for MMP-2, MMP-3, MMP-7, MMP-9,
MMP-10, MMP-11, MMP-17, TIMP-1, and TIMP-3 appear much
less abundant in mouse macrophages (Figure 1B) than human
macrophages (42). Only MMP-8, MMP-14, MMP-19, MMP-25,
and TIMP-2 show similar (within 10-fold) abundance in both
species at the mRNA level. Responses of MMPs and TIMPs to
classical and alternative also present stark contrasts between mice
and men, under the conditions of our experiments. For exam-
ple, expression of MMP-1, MMP-3, MMP-7, MMP-10, MMP-
12, and TIMP-1 was increased by classical activation of human
macrophages, whereas MMP-9 was constitutive (42), in con-
trast to what we observed here (Figure 1B). Furthermore, IFNγ
increased MMP-1, MMP-10, MMP-12, and MMP-14 expression
and decreased TIMP-3 expression in human macrophages (42),
none of which we observed in mouse macrophages at the same
time point (Figure 1C). Finally, IL-4 treatment increased MMP-
11, MMP-12, and TIMP-3 expression in human macrophages (42)
but MMP-19 expression in mice (Figure 1B). Similar disparity has
been previously noted with respect to the expression levels of M1
and M2 markers in human and mouse macrophages (15). More-
over, the overall transcriptomic response to several in vivo models
of inflammation appears highly divergent in mice and men (49).
These limitations therefore caution against over-extrapolating our
present results from a mouse model to human atherosclerosis.
In conclusion, our results definitively counter the hypothe-
sis that lymphocytes are necessary for M1 or M2 polarization
in mouse atherosclerosis, although more work will be needed to
define the mediators responsible. Lymphocytes are also not needed
for MMP and TIMP expression in FCMs in vivo. However, our
studies do not rule out a modulatory role for T or B lympho-
cytes on either macrophage polarization or MMP production. It is
conceivable that deletion of different lymphocyte populations has
opposing effects of macrophage and foam cell activation, leading
to a neutral effect overall. Subsequent studies using more selec-
tive interventions will be needed to investigate the role of specific
lymphocyte subsets in mice.
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